These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 29548654)
1. Recent trends in practice patterns and impact of corticosteroid use on pediatric Mycoplasma pneumoniae-related respiratory infections. Okubo Y; Michihata N; Morisaki N; Uda K; Miyairi I; Ogawa Y; Matsui H; Fushimi K; Yasunaga H Respir Investig; 2018 Mar; 56(2):158-165. PubMed ID: 29548654 [TBL] [Abstract][Full Text] [Related]
2. Recent trends in practice patterns and comparisons between immunoglobulin and corticosteroid in pediatric immune thrombocytopenia. Okubo Y; Michihata N; Morisaki N; Hangai M; Matsui H; Fushimi K; Yasunaga H Int J Hematol; 2018 Jan; 107(1):75-82. PubMed ID: 28849369 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis. Ahn JG; Cho HK; Li D; Choi M; Lee J; Eun BW; Jo DS; Park SE; Choi EH; Yang HJ; Kim KH BMC Infect Dis; 2021 Sep; 21(1):1003. PubMed ID: 34563128 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive Ha SG; Oh KJ; Ko KP; Sun YH; Ryoo E; Tchah H; Jeon IS; Kim HJ; Ahn JM; Cho HK J Korean Med Sci; 2018 Oct; 33(43):e268. PubMed ID: 30344461 [TBL] [Abstract][Full Text] [Related]
6. [The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children]. Bao F; Qu JX; Liu ZJ; Qin XG; Cao B Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):756-61. PubMed ID: 24433804 [TBL] [Abstract][Full Text] [Related]
7. Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance. Cao B; Qu JX; Yin YD; Eldere JV Clin Respir J; 2017 Jul; 11(4):419-429. PubMed ID: 26365811 [TBL] [Abstract][Full Text] [Related]
8. Comparison of high-dose and low-dose corticosteroid therapy for refractory Mycoplasma pneumoniae pneumonia in children. Okumura T; Kawada JI; Tanaka M; Narita K; Ishiguro T; Hirayama Y; Narahara S; Tsuji G; Sugiyama Y; Suzuki M; Tsuji T; Hoshino S; Nakatochi M; Muramatsu H; Kidokoro H; Takahashi Y; Sato Y; J Infect Chemother; 2019 May; 25(5):346-350. PubMed ID: 30718192 [TBL] [Abstract][Full Text] [Related]
9. Macrolide therapy and outcomes in a multicenter cohort of children hospitalized with Mycoplasma pneumoniae pneumonia. Shah SS; Test M; Sheffler-Collins S; Weiss AK; Hall M J Hosp Med; 2012 Apr; 7(4):311-7. PubMed ID: 22271440 [TBL] [Abstract][Full Text] [Related]
10. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy. Lung DC; Chan YH; Kwong L; Que TL Hong Kong Med J; 2011 Oct; 17(5):407-9. PubMed ID: 21979480 [TBL] [Abstract][Full Text] [Related]
11. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. Matsubara K; Morozumi M; Okada T; Matsushima T; Komiyama O; Shoji M; Ebihara T; Ubukata K; Sato Y; Akita H; Sunakawa K; Iwata S J Infect Chemother; 2009 Dec; 15(6):380-3. PubMed ID: 20012728 [TBL] [Abstract][Full Text] [Related]
12. Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children. Lung DC; Yip EK; Lam DS; Que TL Pediatr Infect Dis J; 2013 Dec; 32(12):1396-9. PubMed ID: 23817339 [TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju. Kim YJ; Shin KS; Lee KH; Kim YR; Choi JH J Korean Med Sci; 2017 Oct; 32(10):1642-1646. PubMed ID: 28875608 [TBL] [Abstract][Full Text] [Related]
14. Association of Antibiotic Treatment With Outcomes in Patients Hospitalized for an Asthma Exacerbation Treated With Systemic Corticosteroids. Stefan MS; Shieh MS; Spitzer KA; Pekow PS; Krishnan JA; Au DH; Lindenauer PK JAMA Intern Med; 2019 Mar; 179(3):333-339. PubMed ID: 30688986 [TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients. Kawai Y; Miyashita N; Yamaguchi T; Saitoh A; Kondoh E; Fujimoto H; Teranishi H; Inoue M; Wakabayashi T; Akaike H; Ogita S; Kawasaki K; Terada K; Kishi F; Ouchi K Respirology; 2012 Feb; 17(2):354-62. PubMed ID: 22077195 [TBL] [Abstract][Full Text] [Related]
16. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Okada T; Morozumi M; Tajima T; Hasegawa M; Sakata H; Ohnari S; Chiba N; Iwata S; Ubukata K Clin Infect Dis; 2012 Dec; 55(12):1642-9. PubMed ID: 22972867 [TBL] [Abstract][Full Text] [Related]